Ask Avo acts as a “digital front door” for clinicians, helping them navigate their complex EHR with ease. Ask Avo is actionable, allowing providers to ask for a patient chart summary pre-visit, a care gaps analysis, an ambient note, an order placement, and more. This unique combination of clinical decision support paired with real-time actions not only enhances provider decision-making but also saves them valuable time and improves patient outcomes.

Avo’s clinician support platform empowers healthcare organizations to standardize care and reduce burnout by effortlessly incorporating guidelines and protocols into the clinical workflow. By centralizing the latest information and transforming it into actionable tools in the EHR (or outside of it), Avo simplifies everyday tasks like pre-charting, care planning, documentation, ordering, and more. 

Avo’s foundational product, Avo Pathway, is a medical reference tool that comes with a free library of digitized society guidelines and top calculators. In addition to customizing pre-built templates from leading medical societies and academic medical centers, health systems can leverage their own content to turn pages of guidelines and protocols into useful clinical tools.  

Avo’s time-saving AI product, Avo Assistant, is an end-to-end clinical workflow tool that helps healthcare organizations reduce burnout by automating every day tasks like pre-charting, care planning, documentation (with ambient listening) and ordering. 

The platform is EHR integrated and powered by its "no-code" Avo Builder, which allows systems to use drag-and-drop functionality to customize Avo products. After a quick one-time install, updates can be published immediately without needing IT support. 

Avo was built for clinicians, by clinicians. Randomized control trials have shown that Avo saves clinicians 50% of their time on average and has improved admission delays to the ED by 30%. Importantly, nearly 100% of Avo users advocate for more Avo use cases after implementation. At Avo, we believe there is a better way to standardize care - with love, not alerts. 

• eCART is a research-based, AI-driven software as a medical device (SaMD) that utilizes a machine learning algorithm to continuously assess hospitalized patients’ risk of impending death or intensive care unit (ICU) transfer, assisting medical staff in swift and accurate recognition of patients requiring increased medical attention. eCART draws upon readily available patient data from the EHR, rapidly quantifies disease severity, and predicts likelihood of critical illness onset, hours before it happens.
• eCART received FDA 510(k) clearance in 2024, with clinical performance data of nearly two million hospitalizations from 21 hospitals, including an unprecedented level of real-world prospective data, to ensure consistent accuracy across geography, age, race, and top medical conditions (e.g. sepsis, COPD, heart failure). 
• Built upon more than a decade of ongoing scientific research, eCART was developed at UChicago Medicine by Dr. Dana Edelson, MD, MS and Dr. Matthew Churpek, MD, PhD and is well chronicled in published literature. The analytic and workflow have been in use in clinical practice since 2016.

At AgileMD, we are building the most advanced real-time predictive analytics and clinical pathways platform for hospitals.

To date, AgileMD tools have been used on more than 4 million patient encounters by more than 135,000 clinical users in over 250 hospitals, including some of the nation's leading academic medical centers. AgileMD's eCART clinical deterioration prediction software is FDA cleared and the first AI-powered early warning device for ward patients to go through the FDA process with real-world prospective data. 

AgileMD is backed by premier start-up partners MATTER, YCombinator, and Rock Health, and our cutting-edge analytics are built on more than decade of ongoing research at the University of Chicago. In 2021, AgileMD garnered nearly $3 million in combined federal research and development funding from the U.S. Department of Health and Human Services (HHS), including the National Institutes of Health (NIH) and the Biomedical Advanced Research and Development Authority (BARDA).

Does not exist within most/all EHRs today 

• EHR Integration ond Actionability: Tools not integrated into the EHR are never top-of-mind for clinicians and therefore require a huge investment from health systems to drive up adoption. Additionally, point solutions slow clinicians down instead of streamlining everything they need in one place. Ask Avo is designed to integrate seamlessly into EHR systems, leveraging nationwide patient data from HIEs to provide relevant and trustworthy responses based on the latest system and society guidelines. 
• Customizable, Actionable & Easy to Deploy: AI consult tools currently in the market simply produce a basic clinical summary, aren’t customizable, and lack critical, hospital-specific guidelines that meet the needs of local populations. Additionally, many tools require a tremendous amount of time and effort for IT teams to create, implement, and maintain. Ask Avo is never one-size-fits-all. Using Avo's customizable, back-end Builder, healthcare systems can swiftly customize and upload their own guidelines to Avo’s Knowledge Base and work with Avo’s team of informatics and technical experts to determine various guidelines’ relevance in clinical settings. In other words, health systems are empowered to implement AI within their own determined limits, prioritizing responses based on their guidelines and unique patient populations. 
• Trustworthy, Relevant & Transparent: Studies have shown that, especially in healthcare, ChatGPT is prone to hallucinations and incorrect or irrelevant source citations, in some cases referencing research that does not even exist. Health system decision-makers often lack insight and control into how AI tools on the market will guide their clinicians.Ask Avo is much more than a clinical summary aggregating information from often out-of-date and irrelevant sources. It is designed to generate responses from recent content relevant to the institution whose clinicians are using it. The tool's unique design includes a proprietary questioning system triple verification against trusted guidelines, and offers clinician visibility and control, further enhancing its reliability. 
• In a recent study of Ask Avo, 61 clinicians were asked to question both Ask Avo and ChatGPT 4o with the same 10 clinical prompts that involved questions about complex patient scenarios. After receiving a response, the physicians rated the answers based on trustworthiness, actionability, relevancy, comprehensiveness, and format-friendliness. Ask Avo outperformed ChatGPT 4o on all fronts with an average of 33% better ratings across all criteria and was statistically significantly better. Clinicians' feedback included, “Ask Avo is MUCH better than ChatGPT. I love the citations built directly into the source and the ability to easily pull those citations up on the same tab. I love the "AI Fact-Check" option that makes the limitations clear as well. This is excellent” and “This program cited its sources, which increases my comfort and trust in it tremendously.”

• Continuously monitors EHR data in real time
• Stratifies hospitalized patients by risk of impending all-cause clinical deterioration and sepsis
• Notifies inpatient providers when patient may need additional assessment and management
• Recommends clinical pathways with integrated order entry

• Authorized: FDA 510(k) cleared
• Tested: Derived and validated in nearly 3 million patient encounters across 28 hospitals
• Experienced: 8+ years in clinical use; 10+ years of published academic literature on value over other early warning scores
• Accurate: High sensitiviy and specificity, meaning fewer false alarms and more efficient focus on the highest risk patients
• Integrated: Embedded cross-team workflow ensures that risk scores are not ignored and action is taken
• Benchmarked: Robust reporting, benchmarking, and implementation support drive quality improvement